AMY LUCAS NANCE M.D. NPI 1407032097

NPI Details

Amy Lucas Nance, M.D. is a medical oncology internal medicine in Gainesville, FL with 21 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Amy Lucas Nance, M.D. NPI is 1407032097. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: MERCER UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2005

The provider's business location address is:

6420 W NEWBERRY RD
EAST WING, SUITE 100
GAINESVILLE, FL
ZIP 32605-308
Phone: (352) 332-3900
Fax: (352) 332-5009

The NPI 1407032097 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Magnesium level (HCPCS:83735)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Protein measurement, serum (HCPCS:84165)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Folic acid level, serum (HCPCS:82746)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Automated urinalysis test (HCPCS:81003)
• Red blood count, automated test (HCPCS:85045)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Red blood count, manual test (HCPCS:85044)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)

The enumeration date for this NPI number is 1/14/2008 and was last updated on 8/11/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.